Dai-ichi Life Insurance Company’s Teva Pharmaceuticals TEVA Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$701K	Buy	41,841 +11,797	+39%	+$198K	0.02%	413
2025 Q1	$462K	Sell	30,044 -5,000	-14%	-$76.9K	0.01%	451
2024 Q4	$772K	Sell	35,044 -2,200	-6%	-$48.5K	0.02%	421
2024 Q3	$671K	Sell	37,244 -14,902	-29%	-$269K	0.02%	442
2024 Q2	$847K	Buy	52,146 +2,697	+5%	+$43.8K	0.02%	389
2024 Q1	$698K	Buy	49,449 +5,200	+12%	+$73.4K	0.02%	403
2023 Q4	$462K	Hold	44,249	–	–	0.01%	410
2023 Q3	$451K	Buy	44,249 +1,064	+2%	+$10.9K	0.01%	420
2023 Q2	$325K	Hold	43,185	–	–	0.01%	442
2023 Q1	$382K	Buy	43,185 +3,378	+8%	+$29.9K	0.01%	437
2022 Q4	$363K	Buy	39,807 +4,807	+14%	+$43.8K	0.01%	452
2022 Q3	$282K	Sell	35,000 -7,187	-17%	-$57.9K	0.01%	455
2022 Q2	$317K	Hold	42,187	–	–	0.01%	451
2022 Q1	$396K	Buy	42,187 +1,164	+3%	+$10.9K	0.01%	468
2021 Q4	$329K	Sell	41,023 -7,391	-15%	-$59.3K	﹤0.01%	482
2021 Q3	$472K	Hold	48,414	–	–	0.01%	469
2021 Q2	$479K	Hold	48,414	–	–	0.01%	472
2021 Q1	$559K	Hold	48,414	–	–	0.01%	460
2020 Q4	$467K	Sell	48,414 -25,000	-34%	-$241K	0.01%	446
2020 Q3	$661K	Sell	73,414 -1,013	-1%	-$9.12K	0.01%	420
2020 Q2	$918K	Hold	74,427	–	–	0.02%	386
2020 Q1	$668K	Sell	74,427 -20,000	-21%	-$180K	0.03%	402
2019 Q4	$925K	Buy	94,427 +80,195	+563%	+$786K	0.02%	420
2019 Q3	$98K	Hold	14,232	–	–	﹤0.01%	518
2019 Q2	$131K	Sell	14,232 -20,765	-59%	-$191K	﹤0.01%	533
2019 Q1	$549K	Hold	34,997	–	–	0.01%	452
2018 Q4	$540K	Sell	34,997 -40,000	-53%	-$617K	0.01%	422
2018 Q3	$1.62M	Hold	74,997	–	–	0.04%	359
2018 Q2	$1.82M	Buy	74,997 +61,600	+460%	+$1.5M	0.04%	326
2018 Q1	$229K	Hold	13,397	–	–	﹤0.01%	484
2017 Q4	$254K	Hold	13,397	–	–	﹤0.01%	470
2017 Q3	$236K	Hold	13,397	–	–	0.01%	482
2017 Q2	$445K	Sell	13,397 -4,429	-25%	-$147K	0.01%	436
2017 Q1	$572K	Sell	17,826 -39,254	-69%	-$1.26M	0.02%	430
2016 Q4	$2.07M	Buy	+57,080	New	+$2.07M	0.06%	294